Evidence map›Paper›PMID 31939059›Full record

ArticleJournal of gastrointestinal cancer2020

Identification of Novel Pathogenic Sequence Variants of the Mismatch Repair Genes During Screening for Lynch Syndrome in a Single Centre of Eastern Hungary.

Gergely Kóder, Judit Olasz, Janos L Tanyi, Erin George, László Tóth, Péter Antal-Szalmás, Béla Nagy, Tamás Bubán, Csilla András, Hilda Urbancsek and 4 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Journal of gastrointestinal cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 70% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Gergely KóderDepartment of Surgery, Faculty of General Medicine, Medical and Health Science Centre, University of Debrecen, Móricz Zs. Krt. 22, Debrecen, 4032, Hungary. kodergergely@gmail.com.ORCID http://orcid.org/0000-0003-3914-9171
Judit OlaszDepartment of Pathogenetics, National Institute of Oncology, Budapest, Hungary.
Janos L TanyiDepartment of Obstetrics and Gynecology, Division of Gynecologic Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania Health System, Pennsylvania, PA, USA.
Erin GeorgeDepartment of Obstetrics and Gynecology, Division of Gynecologic Oncology, Perelman Center for Advanced Medicine, University of Pennsylvania Health System, Pennsylvania, PA, USA.
László TóthDepartment of Pathology, Faculty of General Medicine, University of Debrecen, Debrecen, Hungary.
Péter Antal-SzalmásDepartment of Laboratory Medicine, Faculty of General Medicine, University of Debrecen, Debrecen, Hungary.
Béla NagyDepartment of Laboratory Medicine, Faculty of General Medicine, University of Debrecen, Debrecen, Hungary.
Tamás BubánDepartment of Internal Medicine, Faculty of General Medicine, University of Debrecen, Debrecen, Hungary.
Csilla AndrásDepartment of Oncology, Faculty of General Medicine, University of Debrecen, Debrecen, Hungary.
Hilda UrbancsekDepartment of Oncology, Faculty of General Medicine, University of Debrecen, Debrecen, Hungary.
Miklós LaczikR&D Epigenetics Department of Diagenode SA, Liège, Belgium.
Orsolya CsukaDepartment of Pathogenetics, National Institute of Oncology, Budapest, Hungary.
László DamjanovichDepartment of Surgery, Faculty of General Medicine, University of Debrecen, Debrecen, Hungary.
Miklós TanyiDepartment of Surgery, Faculty of General Medicine, University of Debrecen, Debrecen, Hungary.
University of Debrecen · HUNational Institute of Oncology · HUUniversity of Pennsylvania Health System · USDiagenode (Belgium) · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLynch syndrome is an autosomal dominant disorder, most frequent leading to colon cancer. Identification of patients with Lynch syndrome and screening of their family members are available prevention approach that can significantly decrease mortality. Unfortunately, routine screening still does not belong to standard of care in Hungary. In this study, we performed a comprehensive screening in order to identify patients with mismatch repair (MMR) mutation between the years of 2011 and 2014. Identified mutations were compared with those already published in the international databases. PATIENTS AND

methodsPatients who underwent treatment for colorectal cancer at the Surgical Institute of the University of Debrecen were screened using the modified Amsterdam and Bethesda Criteria. Immunohistochemistry and microsatellite analyses were performed in order to identify possible mutation carrier cases. Suspicious cases underwent DNA sequencing to detect mutations in the mismatch repair genes (hMLH1, hMSH2).

resultsAll together 760 colorectal cancer patients were screened. A total of 28 patients were identified as possible MMR mutation carrier and underwent further genetic evaluation. Pathogenic sequence variants of the MMR gene were found in 5 patients. Hypermethylation of the promoter region of the hMLH1 gene was identified in 2 patients. Two out of the 5 pathogenic sequence variants of the MMR gene were first identified by our group while other 2 mutations were previously published as possible founder mutations.

conclusionIdentification of families with Lynch syndrome, while challenging because of variable phenotypes at diagnosis, is feasible with available molecular biological technologies and crucial to reduce mortality caused by this syndrome.

Indexed as

Genetic Predisposition to DiseaseMutationAdultBiomarkers, TumorColorectal Neoplasms, Hereditary NonpolyposisColorectal SurgeryEarly Detection of CancerFemaleFollow-Up StudiesHumansHungaryMaleMutL Protein Homolog 1MutS Homolog 2 ProteinPrognosisSurvival RateBiomarkers, TumorMLH1 protein, humanMSH2 protein, humanMutL Protein Homolog 1MutS Homolog 2 ProteinColorectal cancerLynch syndromeMMR mutationScreening

Identifiers

PMID31939059
PMCPMC7399673
OpenAlexW4238699102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.